Caregivers of Geriatric Patients with Cancer Are Under-Recognized But Critical Members of the Care Team


Caregivers for geriatric patients with cancer are vital members of a patient's care and support system, but often don't get the recognition they deserve.

Older patients with cancer are sure to count their doctors and nurses as vital members of their care teams. But according to Dr. Grant Williams, caregivers are just as important to the overall health of a geriatric patient and should be recognized as such.

Given their proximity to the patient, Williams explained, a caregiver is in the unique position to help a patient focus on the things they can work on in addition to treatment, such as maintaining their nutrition and staying physically active. In an interview with CURE®, Williams went on to note that caregivers should keep in mind that a comprehensive approach to treatment that isn’t solely focused on the cancer is what makes all the difference.


I think that's a great question. You know, caregivers are incredibly important to the overall care and to the team. And that's true, frankly, for all patients.

I think seeking out information and going to places that recognize kind of this comprehensive and global approach to treatment, that isn't just focused on the cancer, but also focused on the person, I think is important. You know, that's variable across places that you may go to.

I also think, for patients and caregivers, focusing on the things that you can alter and improve. And for me, a lot of times, that is the nutrition and the physical activity pieces, to maintaining strength and activity and maintaining nutrition to the best that they can.

And I think just being there as a caregiver is critically important, whether that's emotionally or physically, all of those things. I mean, I think it's an often underrecognized and underappreciated critical aspect of care.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Related Content